• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

减瘤手术及热灌注化疗后腹壁并发症

Abdominal Wall Morbidity Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

作者信息

Struller F, Koenigsrainer I, Horvath P, Koenigsrainer A, Beckert S

机构信息

Department of General, Visceral and Transplant Surgery, University Hospital Tuebingen, Tuebingen, Germany.

出版信息

Scand J Surg. 2017 Dec;106(4):294-298. doi: 10.1177/1457496917690989. Epub 2017 Mar 1.

DOI:10.1177/1457496917690989
PMID:28737098
Abstract

BACKGROUND

Incisional hernia formation has been reported as high as 20% within 1 year following midline laparotomy. Since hyperthermic intraperitoneal chemotherapy is likely to impair wound healing, we sought to investigate the incidence of incisional hernia formation and abdominal wall rupture following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

METHODS

Consecutive patients with radiographic evidence of peritoneal metastases were scheduled for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at the Comprehensive Cancer Center, University Hospital Tuebingen, Germany. Clinical data were retrospectively analyzed.

RESULTS

Between May 2005 and May 2014, 271 patients underwent cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Within follow-up, 19 (7%) incisional hernias and 11 (4%) abdominal wall ruptures were observed. Age ⩾70 years, cardio-pulmonary comorbidity, the presence of pseudomyxoma peritonei or mesothelioma, and postoperative abdominal wall rupture were detected as risk factors for hernia formation. However, Cox multivariate analysis only confirmed the presence of pseudomyxoma peritonei or mesothelioma and postoperative abdominal wall rupture as independent risk factors.

CONCLUSION

Our data do not suggest that cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is necessarily associated with a higher incidence of incisional hernia formation. However, patients suffering from pseudomyxoma peritonei or mesothelioma and patients with postoperative abdominal wall rupture seem to be at risk for developing incisional herniation.

摘要

背景

据报道,中线剖腹手术后1年内切口疝形成率高达20%。由于腹腔内热化疗可能会损害伤口愈合,我们试图研究细胞减灭术和腹腔内热化疗后切口疝形成及腹壁破裂的发生率。

方法

在德国图宾根大学医院综合癌症中心,对有腹膜转移影像学证据的连续患者进行细胞减灭术和腹腔内热化疗。对临床数据进行回顾性分析。

结果

2005年5月至2014年5月期间,271例患者接受了细胞减灭术和腹腔内热化疗。在随访期间,观察到19例(7%)切口疝和11例(4%)腹壁破裂。年龄≥70岁、心肺合并症、腹膜假黏液瘤或间皮瘤的存在以及术后腹壁破裂被检测为疝形成的危险因素。然而,Cox多变量分析仅证实腹膜假黏液瘤或间皮瘤的存在以及术后腹壁破裂是独立危险因素。

结论

我们的数据并不表明细胞减灭术和腹腔内热化疗必然与更高的切口疝形成发生率相关。然而,患有腹膜假黏液瘤或间皮瘤的患者以及术后腹壁破裂的患者似乎有发生切口疝的风险。

相似文献

1
Abdominal Wall Morbidity Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.减瘤手术及热灌注化疗后腹壁并发症
Scand J Surg. 2017 Dec;106(4):294-298. doi: 10.1177/1457496917690989. Epub 2017 Mar 1.
2
Incidence and predictors of incisional hernia after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.细胞减灭术和腹腔内热化疗后切口疝的发生率和预测因素。
Int J Hyperthermia. 2019;36(1):812-816. doi: 10.1080/02656736.2019.1641634.
3
Feasibility of radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin.根治性细胞减灭术和腹腔内热灌注化疗治疗阑尾来源的假性黏液瘤腹膜假性黏液瘤的可行性。
Scand J Surg. 2013;102(3):145-51. doi: 10.1177/1457496913490463.
4
Risk factors and management of incisional hernia after cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal surface malignancies.腹膜表面恶性肿瘤患者细胞减灭术和腹腔内热灌注化疗(HIPEC)后切口疝的风险因素和处理。
Hernia. 2020 Apr;24(2):257-263. doi: 10.1007/s10029-019-01962-4. Epub 2019 May 8.
5
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours in elderly patients: Is it justified?细胞减灭术和腹腔内热化疗治疗老年患者的假性黏液瘤和阑尾肿瘤:是否合理?
Clin Transl Oncol. 2017 Nov;19(11):1388-1392. doi: 10.1007/s12094-017-1728-9. Epub 2017 Aug 10.
6
Increased risk for incisional hernia following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.细胞减灭术联合腹腔内热灌注化疗后切口疝风险增加。
ANZ J Surg. 2023 Sep;93(9):2192-2196. doi: 10.1111/ans.18594. Epub 2023 Jul 10.
7
Peritoneal carcinomatosis from unusual cancer origins: Is there a role for hyperthermic intraperitoneal chemotherapy?罕见癌症起源导致的腹膜癌转移:腹腔内热灌注化疗是否起作用?
J Visc Surg. 2016 Apr;153(2):101-7. doi: 10.1016/j.jviscsurg.2015.11.010. Epub 2015 Dec 11.
8
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin.通过改良灌注系统进行热灌注化疗(HIPEC)的细胞减灭术用于结直肠源性腹膜癌病。
Surg Today. 2016 Aug;46(8):979-84. doi: 10.1007/s00595-016-1335-3. Epub 2016 Apr 30.
9
Timing of Systemic Chemotherapy in Patients With Colorectal Peritoneal Carcinomatosis Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.接受细胞减灭术和腹腔内热灌注化疗的结直肠癌腹膜转移患者全身化疗的时机
Dis Colon Rectum. 2017 May;60(5):477-487. doi: 10.1097/DCR.0000000000000774.
10
An analysis of the morbidity associated with abdominal wall resection and reconstruction after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC).分析细胞减灭术和腹腔内热灌注化疗(CRS/HIPEC)后腹壁切除和重建相关的发病率。
Eur J Surg Oncol. 2019 Mar;45(3):394-399. doi: 10.1016/j.ejso.2018.12.020. Epub 2018 Dec 29.

引用本文的文献

1
Predictors of Incisional Hernia After Cytoreductive Surgery and HIPEC: A Retrospective Analysis.细胞减灭术和腹腔热灌注化疗后切口疝的预测因素:一项回顾性分析
Medicina (Kaunas). 2025 Jul 26;61(8):1356. doi: 10.3390/medicina61081356.
2
Incidence of incisional hernia in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: an observational clinical study from a tertiary oncology referral care center in India.印度一家三级肿瘤转诊治疗中心的观察性临床研究:细胞减灭术和腹腔内热化疗患者切口疝的发生率。
World J Surg Oncol. 2024 May 17;22(1):132. doi: 10.1186/s12957-024-03408-3.
3
Abdominal Closure With Reinforcing Suture Decreases Incisional Hernia Incidence After CRS/HIPEC.
使用加强缝线进行腹部闭合可降低CRS/HIPEC术后切口疝的发生率。
J Abdom Wall Surg. 2023 Mar 9;2:11188. doi: 10.3389/jaws.2023.11188. eCollection 2023.
4
Incisional hernias post cytoreductive surgery/peritonectomy and hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis.细胞减灭术/腹腔热灌注化疗术后切口疝:系统评价和荟萃分析。
Hernia. 2023 Oct;27(5):1067-1083. doi: 10.1007/s10029-023-02859-z. Epub 2023 Aug 31.
5
Hernia and Cancer: The Points Where the Roads Intersect.疝气与癌症:两条道路的交汇点。
Front Surg. 2019 Apr 5;6:19. doi: 10.3389/fsurg.2019.00019. eCollection 2019.
6
Biological mesh is a safe and effective method of abdominal wall reconstruction in cytoreductive surgery for peritoneal malignancy.生物补片是腹膜恶性肿瘤细胞减灭术中腹壁重建的一种安全有效的方法。
BJS Open. 2018 Aug 2;2(6):464-469. doi: 10.1002/bjs5.93. eCollection 2018 Dec.